Company Updates
GasHub Signs MOU with Sinochem
GasHub, focused on gas-piping and energy services has released information in regards to the company to be listed on the Australian Securities Exchange (ASX) in the next few months.
Novogen Ltd Optimistic on Cantrixil as Study Continues
The executives of Australian company Novogen Ltd are confident about the future of the drug Cantrixil as a possible treatment for ovarian cancer.
Credi Features on Sky News
Credi’s CEO was live on Sky News Sydney – the bank of Mum and Dad is a constant reminder of the significant number of Australian’s lending money between family and friends.
AsiaPhos (SGX: 5WV) Achieves 220% YoY Growth in Profit Before Taxation & 67% YoY Revenue Growth to S$16.1m
AsiaPhos Ltd, a Singapore-headquartered mineral resources company focused on exploring and mining phosphate, has announced a 220% YoY growth in profit before taxation and 67% YoY revenue growth.
The Case for Investors Sticking out the Volatility in Bitcoin and Ethereum
During the Month of May, a price correction for bitcoin wiped off nearly $4 billion in its market value.
Imugene (AXS: IMU) Commences Phase 1b/2 Gastric Cancer Study, Receives Approvals to Initiate Clinical Trial & Secures Further Intellectual Property
Imugene Limited (ASX: IMU), an immunoncology company is pleased to release its Appendix 4C for the quarter ended 30th June, 2017.
OncoSil (ASX: OSL) Accelerates Operational Progress with 10 Major Cancer Treatment Centres & Reports $8.0m Cash Balance
OncoSil Medical Ltd (ASX:OSL), a medical device company which focuses on localised treatments for patients with pancreatic and liver cancer, has released its Appendix 4C.
LatAm Autos Receives $6.75m Subscription Funds & Reports Record Cash Receipts & Revenue in Mexico & Ecuador
LatAm Autos Limited (ASX:LAA) has recently announce its cash flow report for the period ended June 30 2017.
YPB Has Strong Expectations of $5million Pre-Tax Profit Expected 2018
YPB Group Ltd (ASX: YPB) has recently provided a summary of activities for the quarter ended 30 June 2017.
Backed By Leading Investment Groups and Family Offices
